CONMED CORP (CNMD) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CNMD - US2074101013 - Common Stock
42.91 USD
-1.29 (-2.92%)
42.91 USD
0 (0%)
Taking everything into account, CNMD scores 6 out of 10 in our fundamental rating. CNMD was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While CNMD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CNMD scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
CNMD had positive earnings in the past year.
In the past year CNMD had a positive cash flow from operations.
Of the past 5 years CNMD 4 years were profitable.
CNMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CNMD's Return On Assets of 2.77% is fine compared to the rest of the industry. CNMD outperforms 76.22% of its industry peers.
With a decent Return On Equity value of 6.38%, CNMD is doing good in the industry, outperforming 79.46% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.39%, CNMD is in the better half of the industry, outperforming 77.30% of the companies in the same industry.
CNMD had an Average Return On Invested Capital over the past 3 years of 5.34%. This is below the industry average of 8.84%.
The last Return On Invested Capital (5.39%) for CNMD is above the 3 year average (5.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| ROIC | 5.39% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
1.3 Margins
With a decent Profit Margin value of 4.77%, CNMD is doing good in the industry, outperforming 76.76% of the companies in the same industry.
In the last couple of years the Profit Margin of CNMD has grown nicely.
The Operating Margin of CNMD (9.99%) is better than 78.38% of its industry peers.
CNMD's Operating Margin has improved in the last couple of years.
The Gross Margin of CNMD (54.22%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CNMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.99% | ||
| PM (TTM) | 4.77% | ||
| GM | 54.22% |
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CNMD is destroying value.
The number of shares outstanding for CNMD has been increased compared to 1 year ago.
The number of shares outstanding for CNMD has been increased compared to 5 years ago.
CNMD has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.90 indicates that CNMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
CNMD has a Altman-Z score of 1.90. This is comparable to the rest of the industry: CNMD outperforms 57.84% of its industry peers.
The Debt to FCF ratio of CNMD is 5.74, which is a neutral value as it means it would take CNMD, 5.74 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.74, CNMD is in the better half of the industry, outperforming 78.38% of the companies in the same industry.
A Debt/Equity ratio of 0.85 indicates that CNMD is somewhat dependend on debt financing.
CNMD has a worse Debt to Equity ratio (0.85) than 72.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.74 | ||
| Altman-Z | 1.9 |
ROIC/WACC0.61
WACC8.9%
2.3 Liquidity
CNMD has a Current Ratio of 2.10. This indicates that CNMD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.10, CNMD is in line with its industry, outperforming 40.54% of the companies in the same industry.
A Quick Ratio of 0.95 indicates that CNMD may have some problems paying its short term obligations.
With a Quick ratio value of 0.95, CNMD is not doing good in the industry: 78.92% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.1 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.49% over the past year.
CNMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.44% yearly.
CNMD shows a small growth in Revenue. In the last year, the Revenue has grown by 4.61%.
Measured over the past years, CNMD shows a small growth in Revenue. The Revenue has been growing by 6.47% on average per year.
EPS 1Y (TTM)16.49%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%2.86%
Revenue 1Y (TTM)4.61%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%6.7%
3.2 Future
Based on estimates for the next years, CNMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.44% on average per year.
Based on estimates for the next years, CNMD will show a small growth in Revenue. The Revenue will grow by 5.19% on average per year.
EPS Next Y10.38%
EPS Next 2Y4.62%
EPS Next 3Y6.36%
EPS Next 5Y9.44%
Revenue Next Year5.12%
Revenue Next 2Y2.86%
Revenue Next 3Y3.63%
Revenue Next 5Y5.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.49, the valuation of CNMD can be described as reasonable.
Based on the Price/Earnings ratio, CNMD is valued cheaper than 94.59% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.19, CNMD is valued rather cheaply.
A Price/Forward Earnings ratio of 9.42 indicates a reasonable valuation of CNMD.
Based on the Price/Forward Earnings ratio, CNMD is valued cheaper than 95.68% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CNMD to the average of the S&P500 Index (23.92), we can say CNMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.49 | ||
| Fwd PE | 9.42 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CNMD is valued cheaply inside the industry as 91.35% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CNMD is valued cheaper than 98.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.94 | ||
| EV/EBITDA | 10.27 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CNMD may justify a higher PE ratio.
PEG (NY)0.91
PEG (5Y)1.01
EPS Next 2Y4.62%
EPS Next 3Y6.36%
5. Dividend
5.1 Amount
CNMD has a Yearly Dividend Yield of 1.81%.
Compared to an average industry Dividend Yield of 0.19, CNMD pays a better dividend. On top of this CNMD pays more dividend than 95.68% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, CNMD has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.81% |
5.2 History
The dividend of CNMD decreases each year by -0.01%.
CNMD has paid a dividend for at least 10 years, which is a reliable track record.
CNMD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
CNMD pays out 39.73% of its income as dividend. This is a sustainable payout ratio.
DP39.73%
EPS Next 2Y4.62%
EPS Next 3Y6.36%
42.91
-1.29 (-2.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.3%
Inst Owner Change-0.17%
Ins Owners0.29%
Ins Owner Change0.35%
Market Cap1.33B
Revenue(TTM)1.35B
Net Income(TTM)64.32M
Analysts73.33
Price Target49.37 (15.05%)
Short Float %7.67%
Short Ratio4.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.81% |
Yearly Dividend0.8
Dividend Growth(5Y)-0.01%
DP39.73%
Div Incr Years0
Div Non Decr Years12
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.52%
Min EPS beat(2)0.37%
Max EPS beat(2)0.66%
EPS beat(4)4
Avg EPS beat(4)6.26%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.08%
EPS beat(12)10
Avg EPS beat(12)-0.4%
EPS beat(16)13
Avg EPS beat(16)0.52%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-1.03%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)3
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.61%
PT rev (1m)-10.37%
PT rev (3m)-21.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.42%
EPS NY rev (1m)0%
EPS NY rev (3m)0.73%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.49 | ||
| Fwd PE | 9.42 | ||
| P/S | 0.99 | ||
| P/FCF | 8.94 | ||
| P/OCF | 7.94 | ||
| P/B | 1.32 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.27 |
EPS(TTM)4.52
EY10.53%
EPS(NY)4.55
Fwd EY10.61%
FCF(TTM)4.8
FCFY11.19%
OCF(TTM)5.4
OCFY12.59%
SpS43.51
BVpS32.56
TBVpS-12.65
PEG (NY)0.91
PEG (5Y)1.01
Graham Number57.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| ROCE | 6.7% | ||
| ROIC | 5.39% | ||
| ROICexc | 5.5% | ||
| ROICexgc | 19.04% | ||
| OM | 9.99% | ||
| PM (TTM) | 4.77% | ||
| GM | 54.22% | ||
| FCFM | 11.04% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
ROICexc(3y)5.41%
ROICexc(5y)5.04%
ROICexgc(3y)20.03%
ROICexgc(5y)18.26%
ROCE(3y)6.64%
ROCE(5y)6.18%
ROICexgc growth 3Y14.62%
ROICexgc growth 5Y8.81%
ROICexc growth 3Y13.67%
ROICexc growth 5Y10.96%
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
F-Score5
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.74 | ||
| Debt/EBITDA | 4.09 | ||
| Cap/Depr | 25.13% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.15% | ||
| Profit Quality | 231.2% | ||
| Current Ratio | 2.1 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.9 |
F-Score5
WACC8.9%
ROIC/WACC0.61
Cap/Depr(3y)25.34%
Cap/Depr(5y)23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.49%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%2.86%
EPS Next Y10.38%
EPS Next 2Y4.62%
EPS Next 3Y6.36%
EPS Next 5Y9.44%
Revenue 1Y (TTM)4.61%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%6.7%
Revenue Next Year5.12%
Revenue Next 2Y2.86%
Revenue Next 3Y3.63%
Revenue Next 5Y5.19%
EBIT growth 1Y-35.26%
EBIT growth 3Y23.86%
EBIT growth 5Y16.64%
EBIT Next Year42.06%
EBIT Next 3Y15.06%
EBIT Next 5YN/A
FCF growth 1Y296.53%
FCF growth 3Y16.67%
FCF growth 5Y15.46%
OCF growth 1Y191.56%
OCF growth 3Y14.3%
OCF growth 5Y11.92%
CONMED CORP / CNMD FAQ
What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CNMD.
Can you provide the valuation status for CONMED CORP?
ChartMill assigns a valuation rating of 8 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.
How profitable is CONMED CORP (CNMD) stock?
CONMED CORP (CNMD) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for CNMD stock?
The Price/Earnings (PE) ratio for CONMED CORP (CNMD) is 9.49 and the Price/Book (PB) ratio is 1.32.
What is the expected EPS growth for CONMED CORP (CNMD) stock?
The Earnings per Share (EPS) of CONMED CORP (CNMD) is expected to grow by 10.38% in the next year.